Genistein derivatives regioisomerically substituted at 7-O- and 4′-O- have different effect on the cell cycle

Journal of Chemistry

Volumn 2013, Issue , 2013, Pages

  Byczek, A ^a   Zawisza Puchalka, J ^b   Gruca, A ^b   Papaj, K ^b   Grynkiewicz, G ^c   Rusin, M ^a   Szeja, W ^b   Rusin, A ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^c INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897814592     PISSN: 20909063     EISSN: 20909071     Source Type: Journal    
DOI: 10.1155/2013/191563     Document Type: Article

References (41)

1. Kyle J. A. M., Duthie G. G., Andersen M. Ø., Markham K. R., Quideau S., Flavonoids in foods. Flavonoids: Chemistry, Biochemistry, and Applications 2006 Boca Raton, Fla, USA Taylor & Francis 219 262
2. Casagrande F., Darbon J.-M., Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochemical Pharmacology 2001 61 10 1205 1215 2-s2.0-0035874028 10.1016/S0006-2952(01)00583-4 (Pubitemid 32375112)
3. Zapata-Torres G., Opazo F., Salgado C., Muñoz J. P., Krautwurst H., Mascayano C., Sepúlveda-Boza S., Maccioni R. B., Cassels B. K., Effects of natural flavones and flavonols on the kinase activity of Cdk5. Journal of Natural Products 2004 67 3 416 420 2-s2.0-1642546984 10.1021/np034011s (Pubitemid 38405705)
4. Chang K.-L., Kung M.-L., Chow N.-H., Su S.-J., Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochemical Pharmacology 2004 67 4 717 726 2-s2.0-1642575107 10.1016/j.bcp.2003.10.003 (Pubitemid 38125255)
5. Salti G. I., Grewal S., Mehta R. R., Das Gupta T. K., Boddie A. W. Jr., Constantinou A. I., Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. European Journal of Cancer 2000 36 6 796 802 2-s2.0-0034033956 10.1016/S0959-8049(00)00017-4 (Pubitemid 30179753)
6. Banerjee S., Li Y., Wang Z., Sarkar F. H., Multi-targeted therapy of cancer by genistein. Cancer Letters 2008 269 2 226 242 2-s2.0-48749117943 10.1016/j.canlet.2008.03.052
7. Rusin A., Krawczyk Z., El-Shemy H., Genistein derivatization-from a dietary supplement to a pharmaceutical agent. Soybean and Health 2011 Zagreb, Croatia InTech 253 282
8. Rusin A., Krawczyk Z., Grynkiewicz G., Gogler A., Zawisza-Puchałka J., Szeja W., Synthetic derivatives of genistein, their properties and possible applications. Acta Biochimica Polonica 2010 57 1 23 34 2-s2.0-77953252302
9. 2OS human osteosarcoma cells: structure-activity relationships. Journal of Steroid Biochemistry and Molecular Biology 2010 120 4-5 184 191 2-s2.0-77953621900 10.1016/j.jsbmb.2010.04.014
10. Rusin A., Gogler A., Gruca A., Bochenek D., Zawisza J., Szeja W., Grynkiewicz G., Krawczyk Z., Genistein derivatives potentiate inhibition of cancer cells growth by irradiation. FEBS Journal 2009 276 supplement 1 340 341
11. Rusin A., Zawisza-Puchałka J., Kujawa K., Gogler-Pigłowska A., Wietrzyk J., Świtalska M., Głowala-Kosińska M., Gruca A., Szeja W., Krawczyk Z., Grynkiewicz G., Synthetic conjugates of genistein affecting proliferation and mitosis of cancer cells. Bioorganic and Medicinal Chemistry 2011 19 1 295 305 2-s2.0-78650737346 10.1016/j.bmc.2010.11.024
12. Polkowski K., Popiołkiewicz J., Krzeczyński P., Ramza J., Pucko W., Zegrocka-Stendel O., Boryski J., Skierski J. S., Mazurek A. P., Grynkiewicz G., Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines. Cancer Letters 2004 203 1 59 69 2-s2.0-10744221044 10.1016/j.canlet.2003.08.023 (Pubitemid 37506084)
13. Zhang L. N., Xiao Z. P., Ding H., Ge H. M., Xu C., Zhu H. L., Tan R. X., Synthesis and cytotoxic evaluation of novel 7-O-modified genistein derivatives. Chemistry & Biodiversity 2007 4 2 248 255 (Pubitemid 46929195)
14. Hu G.-X., Zhao B.-H., Chu Y.-H., Zhou H.-Y., Akingbemi B. T., Zheng Z.-Q., Ge R.-S., Effects of genistein and equol on human and rat testicular 3 Β -hydroxysteroid dehydrogenase and 17 Β -hydroxysteroid dehydrogenase 3 activities. Asian Journal of Andrology 2010 12 4 519 526 2-s2.0-77954390674 10.1038/aja.2010.18
15. Rusin A., Chrubasik M., Papaj K., Grynkiewicz G., Szeja W., C-Glycosidic genistein conjugates and their antiproliferative activity. Journal of Chemistry 2013 2013 14 951392 10.1155/2013/951392
16. Gogler-Piglowska A., Rusin A., Bochenek D., Krawczyk Z., Aneugenic effects of the genistein glycosidic derivative substituted at C7 with the unsaturated disaccharide. Cell Biology and Toxicology 2012 28 5 331 342
17. Rusin A., Gogler A., Głowala-Kosińska M., Bochenek D., Gruca A., Grynkiewicz G., Zawisza J., Szeja W., Krawczyk Z., Unsaturated genistein disaccharide glycoside as a novel agent affecting microtubules. Bioorganic and Medicinal Chemistry Letters 2009 19 17 4939 4943 2-s2.0-68349144404 10.1016/j.bmcl.2009.07.089
18. Metzler M., Pfeiffer E., Effects of estrogens on microtubule polymerization in vitro: correlation with estrogenicity. Environmental Health Perspectives 1995 103 7 21 22 2-s2.0-0028840610
19. Mukherjee S., Acharya B. R., Bhattacharyya B., Chakrabarti G., Genistein arrests cell cycle progression of A549 cells at the G 2/M phase and depolymerizes interphase microtubules through binding to a unique site of tubulin. Biochemistry 2010 49 8 1702 1712 2-s2.0-77749304742 10.1021/bi901760d
20. Lewis P. T., Wähälä K., Hoikkala A., Mutikainen I., Meng Q.-H., Adlercreutz H., Tikkanen M. J., Synthesis of antioxidant isoflavone fatty acid esters. Tetrahedron 2000 56 39 7805 7810 2-s2.0-0034703490
21. Szeja W., Puchałka J., Świerk P., Hendrich A. B., Grynkiewicz G., Selective alkylation of genistein and daidzein. Chemistry & Biology Interface 2013 3 95 106
22. Bunz F., Hwang P. M., Torrance C., Waldman T., Zhang Y., Dillehay L., Williams J., Lengauer C., Kinzler K. W., Vogelstein B., Disruption of p53 in human cancer cells alters the responses to therapeutic agents. The Journal of Clinical Investigation 1999 104 3 263 269 2-s2.0-0032701521
23. Zajkowicz A., Rusin M., The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases. Mechanisms of Ageing and Development 2011 132 11-12 543 551 2-s2.0-83755202384 10.1016/j.mad.2011.09.002
24. Klaude M., Eriksson S., Nygren J., Ahnström G., The comet assay: mechanisms and technical considerations. Mutation Research 1996 363 2 89 96 2-s2.0-0030580947 10.1016/0921-8777(95)00063-1 (Pubitemid 26225011)
25. Wojewódzka M., Buraczewska I., Kruszewski M., A modified neutral comet assay: elimination of lysis at high temperature and validation of the assay with anti-single-stranded DNA antibody. Mutation Research 2002 518 1 9 20 2-s2.0-0037182814 10.1016/S1383-5718(02)00070-0 (Pubitemid 34626841)
26. Fenech M., The in vitro micronucleus technique. Mutation Research 2000 455 1-2 81 95 2-s2.0-0034693730 10.1016/S0027-5107(00)00065-8
27. Gurova K. V., Rokhlin O. W., Budanov A. V., Burdelya L. G., Chumakov P. M., Cohen M. B., Gudkov A. V., Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells. Cancer Research 2003 63 11 2905 2912 2-s2.0-0037567586 (Pubitemid 36667163)
28. Bartek J., Lukas J., Mammalian G1- and S-phase checkpoints in response to DNA damage. Current Opinion in Cell Biology 2001 13 6 738 747 2-s2.0-0035545996 10.1016/S0955-0674(00)00280-5 (Pubitemid 33042735)
29. Schmidt F., Knobbe C. B., Frank B., Wolburg H., Weller M., The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines. Oncology Reports 2008 19 4 1061 1066 2-s2.0-43849086499 (Pubitemid 351802681)
30. Moll U. M., Petrenko O., The MDM2-p53 interaction. Molecular Cancer Research 2003 1 14 1001 1008 2-s2.0-0346455771 (Pubitemid 38044975)
31. Hardie D. G., AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function. Genes & Development 2011 25 18 1895 1908 2-s2.0-80053035284 10.1101/gad.17420111
32. Kroemer G., Mariño G., Levine B., Autophagy and the integrated stress response. Molecular Cell 2010 40 2 280 293 2-s2.0-78649338141 10.1016/j.molcel.2010.09.023
33. Bampton E. T. W., Goemans C. G., Niranjan D., Mizushima N., Tolkovsky A. M., The dynamics of autophagy visualized in live cells: from autophagosome formation to fusion with endo/lysosomes. Autophagy 2005 1 1 23 36 2-s2.0-19444382327
34. Oblak M., Randic M., Solmajer T., Quantitative structure-activity relationship of flavonoid analogues. 3. Inhibition of p56lck protein tyrosine kinase. Journal of Chemical Information and Computer Sciences 2000 40 4 994 1001 2-s2.0-0034222395
35. Nikolovska-Coleska Z., Suturkova L., Dorevski K., Krbavcic A., Solmajer T., Quantitative structure-activity relationship of flavonoid inhibitors of p56(lck) protein tyrosine kinase: a Classical/Quantum chemical approach. Quantitative Structure-Activity Relationships 1998 17 1 7 13 2-s2.0-0031881498 (Pubitemid 28083398)
36. Machida K., Osawa K., On the flavonoid constituents from the peels of citrus-hassaku hort ex tanaka. Chemical & Pharmaceutical Bulletin 1989 37 4 1092 1094
37. Pan M.-H., Chen W.-J., Lin-Shiau S.-Y., Ho C.-T., Lin J.-K., Tangeretin induces cell-cyle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002 23 10 1677 1684 2-s2.0-0036799151 (Pubitemid 35214953)
38. Aguero M. F., Facchinetti M. M., Sheleg Z., Senderowicz A. M., Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1. Cancer Research 2005 65 8 3364 3373 2-s2.0-17144381683 (Pubitemid 40524621)
39. Klein C. B., King A. A., Genistein genotoxicity: critical considerations of in vitro exposure dose. Toxicology and Applied Pharmacology 2007 224 1 1 11 2-s2.0-34548642951 10.1016/j.taap.2007.06.022 (Pubitemid 47404623)
40. Bandele O. J., Clawson S. J., Osheroff N., Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement. Chemical Research in Toxicology 2008 21 6 1253 1260 2-s2.0-47049094564 10.1021/tx8000785 (Pubitemid 351967390)
41. Bandele O. J., Osheroff N., The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells. Biochemistry 2008 47 45 11900 11908 2-s2.0-55849119882 10.1021/bi800981j